Feature | July 15, 2007| Cristen C. Bolan

CMS Questions CTA’s Adoption for CAD

Guest Editor for Diagnostic & Invasive Cardiology

In the new order of the day, many experts believe that CT angiography (CTA) will replace invasive cardiac catheterization as the primary diagnostic tool for detecting coronary artery disease (CAD) and disorders. This notion has been backed by heavy investments from vendors in clinical trials that may shore up supporting data.
Recently, Toshiba launched one of the largest clinical trials to date, the Toshiba CorE 64 trial, to evaluate the use of 64-slice CT technology. One of the trial’s objectives is to determine if CT could be a diagnostic alternative to cardiac catheterization. If the results prove to be in CT’s favor, trials like this may be justification enough for cardiac CTA to become the gold standard for diagnosing CAD.
But before you write off cardiac catheterization, the Centers for Medicare and Medicaid Services (CMS) is not yet convinced. CMS considers substituting cardiac cath with CTA potentially risky due to the lack of clinical data supporting positive patient outcomes, and, on June 13 of this year, it initiated a National Coverage Analysis (NCA) regarding CTA. CMS states on its Web site (http://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=206) that while “[p]roponents have claimed that the use of cardiac CTA will lead to better health outcomes and a reduction in cardiac catheterization, the current standard for diagnosis of coronary artery disease…CMS is concerned that despite the lack of clinical evidence to demonstrate improved patient health outcomes with CTA, the procedure has been rapidly adopted by the clinical community.”
CMS indicates that the NCA will evaluate the available evidence for CTA when used to diagnose CAD to determine if a national coverage determination (NCD) is warranted. Plus, the organization has called out for public comments and clinical studies that evaluate CTA technology.
CMS has given the public and the industry 30 days to respond before deciding on whether the situation merits the proposed NCD. So before you substitute cardiac cath with CTA, you might want to wait a few days.

We welcome your comments on the topics found in Diagnostic & Invasive Cardiology.
Please send your thoughts to [email protected]
Please send press releases to [email protected]
and chart responses to [email protected]

Related Content

Siemens Healthineers, Somatom Drive CT system, FDA clearance
Technology | Computed Tomography (CT)| August 30, 2016
Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Somatom Drive computed...
CT angiography, CTA, coronary CT, cardiac CT, SCCT, society of cardiovascular computed tomography, cardiac imaging
Feature | CT Angiography (CTA)| August 03, 2016 | Dave Fornell
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting offers an in-depth review of all aspects of c
CT angiography, CTA, Medicare population, Harvey L. Neiman Health Policy Institute study, Neiman HPI
News | CT Angiography (CTA)| August 02, 2016
According to a new study, the last 13 years have seen substantial growth in the ordering of computed tomography...
Sponsored Content | Videos | CT Angiography (CTA)| July 08, 2016
Interview with Patricia Dickson, LRT (CT), assistant director, diagnostic and outpatient services, Capital Cardiology
Sponsored Content | Videos | Computed Tomography (CT)| July 08, 2016
Interview with Claudio Smuclovisky, M.D., FACC, FSCCT, director of South Florida Imaging Cardiovascular Institute, Ho
Sponsored Content | Videos | Computed Tomography (CT)| July 07, 2016
DAIC/ITN editor Dave Fornell shows some of the most innovative new cardiac CT and angiography technologies from sessi
Sponsored Content | Videos | Computed Tomography (CT)| July 07, 2016
An interview with Matthew Budoff, M.D., FACC, director of cardiac CT, Harbor-UCLA Medical Center, Torrance, Calif., a
Sponsored Content | Videos | Computed Tomography (CT)| July 06, 2016
An interview with Leslee Shaw, Ph.D, FACC, FASNC, FAHA, co-director of the Emory Clinical Cardiovascular Research Ins
Sponsored Content | Videos | CT Angiography (CTA)| July 06, 2016
An interview with Ricardo Cury, M.D., director of cardiac imaging, Miami Cardiac and Vascular Institute, at the Socie
HeartFlow, FFR-CT Analysis, next-generation platform, second FDA clearance
Technology | CT Angiography (CTA)| June 29, 2016
HeartFlow Inc. announced that it is launching its next generation of the HeartFlow FFR-CT Analysis. The result of years...
Overlay Init